Summary
The product AOD 9604 purple top vial, submitted by Alchemist Peptides, underwent independent laboratory testing to verify its composition and purity. The sample, identified by Task Number #45424, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical and peptide quality control. The analysis confirmed the presence of AOD-9604 at a concentration of 2.13 mg with a purity of 99.173%.
The testing process began on 4 July 2024, with the sample received on 15 July 2024, and analysis completed on 17 July 2024. While the results indicate high purity, it’s important to acknowledge that manufacturer-submitted samples may not always represent the consistency of all batches. Independent third-party testing remains crucial for broader validation. This report is provided for educational and harm reduction purposes to support informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Alchemist Peptides
- Product Name: AOD 9604 purple top vial
- Active Ingredient: AOD-9604
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Raw Powder
Testing Details
- Task Number: #45424
- Testing Ordered: 4 July 2024
- Sample Received: 15 July 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Alchemist Peptides (Manufacturer)
- Analysis Paid For By: Alchemist Peptides (Manufacturer)
Testing Results
- Specification: Not provided
- Measured Concentration: 2.13 mg
- Purity: 99.173%
Verification Details
- Verification URL: https://janoshik.com/tests/45424_UBJ3FQFA4DKR
Evaluation of Manufacturer-Submitted Testing
While these results confirm a high purity level, it’s essential to be aware that Alchemist Peptides submitted this sample for testing. Manufacturer often select high-quality batches for testing, which may not accurately reflect the consistency of products available to consumers. Although Janoshik Analytical follows rigorous testing protocols, independent verification through multiple batch testing would provide a more complete picture of product reliability.
Conclusion
The analysis confirms that AOD 9604 purple top vial contains 2.13 mg of AOD-9604 with a purity of 99.173%. This suggests that the tested batch meets high-quality standards; however, further independent testing is recommended for batch consistency validation. This report serves as an educational tool for harm reduction and transparency in the peptide industry.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may contain inherent biases; however, it still provides valuable insights when critically assessed alongside third-party or independent test results. Readers are encouraged to use this information responsibly.
